Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Journal of Biotechnology ; (12): 4413-4427, 2023.
Artículo en Chino | WPRIM | ID: wpr-1008033

RESUMEN

Adenosine triphosphate (ATP) regeneration systems are essential for efficient biocatalytic phosphoryl transfer reactions. Polyphosphate kinase (PPK) is a versatile enzyme that can transfer phosphate groups among adenosine monophosphate (AMP), adenosine diphosphate (ADP), ATP, and polyphosphate (Poly P). Utilization of PPK is an attractive solution to address the problem of ATP regeneration due to its ability to use a variety of inexpensive and stable Poly P salts as phosphate group donors. This review comprehensively summarizes the structural characteristics and catalytic mechanisms of different types of PPKs, as well as the variations in enzyme activity, catalytic efficiency, stability, and coenzyme preference observed in PPKs from different sources. Moreover, recent advances in PPK-mediated ATP regeneration systems and protein engineering of wild-type PPK are summarized.


Asunto(s)
Adenosina Trifosfato/metabolismo , Adenosina Monofosfato , Polifosfatos/metabolismo , Catálisis , Regeneración
2.
Chinese Journal of Biotechnology ; (12): 4669-4680, 2022.
Artículo en Chino | WPRIM | ID: wpr-970339

RESUMEN

Polyphosphate kinase plays an important role in the catalytic synthesis of ATP in vitro. In order to find a polyphosphate kinase that can efficiently synthesize ATP using short-chain polyphosphate (polyP) as substrate, the polyphosphate kinase 2 (PPK2) from Sphingobacterium siyangensis was cloned and expressed in Escherichia coli BL21(DE3). As an enzyme for ATP regeneration, PPK2 was used in combination with l-amino acid ligase (YwfE) to produce l-alanyl-l-glutamine (Ala-Gln). The length of ppk2 of S. siyangensis is 810 bp, encoding 270 amino acids. The SDS-PAGE showed that PPK2 was expressed correctly and its molecular weight was 29.7 kDa as expected. The reaction conditions of PPK2 were optimized. PPK2 could maintain good activity in the range of 22-42 ℃ and pH 7-10. The highest enzyme activity was observed at 37 ℃, pH 7, 30 mmol/L magnesium ion (Mg2+), 5 mmol/L ADP and 10 mmol/L sodium hexametaphosphate, and the yield of ATP reached 60% of the theoretical value in 0.5 hours at this condition. When used in combination with YwfE to produce Ala-Gln, the PPK2 showed a good applicability as an ATP regeneration system, and the effect was similar to that of direct addition of ATP. The PPK2 from S. siyangensis shows good performance in a wide range of temperature and pH, synthesizes ATP with cheap and readily available short chain polyP as substrate. The PPK2 thus provides a new enzyme source for ATP dependent catalytic reaction system.


Asunto(s)
Sphingobacterium/metabolismo , Fosfotransferasas (Aceptor del Grupo Fosfato)/metabolismo , Aminoácidos , Adenosina Trifosfato , Regeneración , Polifosfatos/metabolismo
3.
Biol. Res ; 48: 1-6, 2015. ilus, tab
Artículo en Inglés | LILACS | ID: biblio-950786

RESUMEN

BACKGROUND: Pseudomonas aeruginosa is known to be a multidrug resistant opportunistic pathogen. Particularly, P. aeruginosa PAO1 polyphosphate kinase mutant (ppk1) is deficient in motility, quorum sensing, biofilm formation and virulence. FINDINGS: By using Phenotypic Microarrays (PM) we analyzed near 2000 phenotypes of P. aeruginosa PAO1 polyP kinase mutants (ppk1 and ppk2). We found that both ppk mutants shared most of the phenotypic changes and interestingly many of them related to susceptibility toward numerous and different type of antibiotics such as Ciprofloxacin, Chloramphenicol and Rifampicin. CONCLUSIONS: Combining the fact that ppk1 mutants have reduced virulence and are more susceptible to antibiotics, polyP synthesis and particularly PPK1, is a good target for the design of molecules with anti-virulence and anti-persistence properties.


Asunto(s)
Pseudomonas aeruginosa/enzimología , Fosfotransferasas (Aceptor del Grupo Fosfato)/genética , Farmacorresistencia Bacteriana Múltiple/genética , Análisis por Micromatrices/métodos , Mutación , Fenotipo , Polifosfatos/metabolismo , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/patogenicidad , Rifampin/farmacología , Virulencia/genética , Ciprofloxacina/farmacología , Cloranfenicol/farmacología , Antibacterianos/farmacología
4.
P. R. health sci. j ; 19(1): 19-27, mar. 2000. tab, graf
Artículo en Inglés | LILACS | ID: lil-260839

RESUMEN

Nucleoside reverse transcriptase inhibitors (NRTIs) plasma concentrations do not correlate with clinical efficacy or toxicity. These agents need to be phosphorylated to become active against HIV-infection. Thus, the characterization of the NRTIs intracellular metabolite pharmacological parameters will provide a better understanding that could lead to the development of more rational dose regimens in the HIV-infected population. Furthermore, intracellular measurements of NRTIs may provide a better marker with respect to clinical efficacy and toxicity than plasma concentrations. Thus, in this article we review the latest information regarding the intracellular pharmacological parameters of zidovudine (ZDV) and lamivudine (3TC) active metabolites in HIV infected patients including the results from our recent clinical studies. We will start the discussion with ZDV and 3TC clinical efficacy, followed by systemic pharmacokinetics studies. We will then discuss the in vitro and in vivo intracellular studies with particular emphasis in the method development to measure these metabolites and we will conclude with the most current data from our clinical trials.


Asunto(s)
Humanos , Masculino , Femenino , Niño , Adulto , Persona de Mediana Edad , Fármacos Anti-VIH/farmacocinética , Antimetabolitos/farmacocinética , Lamivudine/farmacocinética , Leucocitos Mononucleares/metabolismo , Inhibidores de la Transcriptasa Inversa/farmacocinética , Zidovudina/farmacocinética , Fármacos Anti-VIH/administración & dosificación , Fármacos Anti-VIH/sangre , Antimetabolitos/administración & dosificación , Antimetabolitos/sangre , Células Cultivadas , Cromatografía Líquida de Alta Presión , Ensayos Clínicos como Asunto , Infecciones por VIH/tratamiento farmacológico , Lamivudine/administración & dosificación , Lamivudine/sangre , Fosfatos/metabolismo , Fosforilación , Polifosfatos/metabolismo , Radioinmunoensayo , Inhibidores de la Transcriptasa Inversa/administración & dosificación , Inhibidores de la Transcriptasa Inversa/sangre , Factores de Tiempo , Zidovudina/administración & dosificación , Zidovudina/sangre
5.
An. acad. bras. ciênc ; 62(4): 401-8, dez. 1990. tab
Artículo en Inglés | LILACS | ID: lil-94999

RESUMEN

The water-snake Liophis miliaris presentes hemoglobin which binds organic polyphosphate through a simple single-site per tetramer (Mol. Wt. 64500) as judged by titration curves of reduced nicotinamide adenine dinucleotide phosphate either in the presence or absence of inositol hexaphosphate. The site seems to have the same structural nature of that found on other hemoglobins and is able to strongly bind most of the known protein effectors such as inositol hexaphosphate, adenosine triphosphate or 2,3-disphosphoglicerate. The high association constant at pØ7 of reduced nicotinamide for the deoxy hemoglobin of about K (D) = 7 x 10***6 M***-1 comparaed to human hemoglobin (K(D) = 7 x 10***5 M***-1), and to that of adenosine triphosphate (its natural erythrocytic polyphosphate) still higher of about K(D) = 10***11 M ***-1, shows clearly the very high affinity of this snake hemoglobin for such allosteric effector. The results besides corroborating the dimer-tetramer transition mechanism proposed to describe the oxygen transport by the hemoglobin of Liophis miliaris - may explain the difficulties to obtain the oxy dimeric conformation of the protein by usual hemolysis and stripped off procedures


Asunto(s)
Animales , Hemoglobinas/metabolismo , Polifosfatos/metabolismo , Serpientes/sangre , Adenosina Trifosfato/metabolismo , Sitios de Unión , NADP/metabolismo , Oxígeno/sangre , Ácido Fítico/metabolismo , Espectrometría de Fluorescencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA